CalciMedica
Stock Forecast, Prediction & Price Target

CalciMedica Financial Estimates

CalciMedica Revenue Estimates

CalciMedica EBITDA Estimates

CalciMedica Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $12.5M
Low: $12.5M
High: $12.5M
avg. 0%
Avg: $2.8M
Low: $2.8M
High: $2.8M
avg. -77.60%
Net Income
 
% change YoY
$-35.82M
 
N/A
$-35.60M
 
0.60%
$-34.35M
 
3.50%
Avg: $-27.86M
Low: $-8.12M
High: $-7.22M
avg. 18.89%
Avg: $-32.45M
Low: $-8.89M
High: $-6.15M
avg. -16.44%
EBITDA
 
% change YoY
$-35.94M
 
N/A
$-29.91M
 
16.77%
$-34.18M
 
-14.28%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$23.66
 
N/A
-$23.2
 
1.94%
-$7.65
 
67.02%
Avg: -$1.71
Low: -$1.81
High: -$1.61
avg. 77.64%
Avg: -$1.68
Low: -$1.98
High: -$1.37
avg. 2.04%
Operating Expenses
 
% change YoY
$35.94M
 
N/A
$33.21M
 
-7.59%
$21.81M
 
-34.31%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is CalciMedica stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 1.22% in 2025-2026.

We have gathered data from 2 analysts. Their low estimate is -8.12M, average is -27.86M and high is -7.22M.

What is CalciMedica stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of -38.80% in 2025-2026.

We have gathered data from 3 analysts. Their low revenue estimate is $12.5M, average is $12.5M and high is $12.5M.

What is CalciMedica stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 39.84% in 2025-2026.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.81, average is -$1.71 and high is $-1.61.

What is the best performing analyst?

In the last twelve months analysts have been covering CalciMedica stock. The most successful analyst is Leland Gershall.